Oncology

Immune-checkpoint engagement as predictive biomarkers in clear cell renal cell carcinoma and melanoma
Lissete Magraner Sanchez, James Miles, Claire Baker, Christopher J Applebee, Dae-Jin Lee, Somaia Elsheikh, Shaimaa Lashin, Katriona Withers, Andrew Watts, Richard Parry, Christine Edmead, Jose Ignacio Lopez, Raj Mehta, Stephen G Ward, Peter J Parker, Banafshe Larijani

medRxiv 2020.01.15.20017517; doi: https://doi.org/10.1101/2020.01.15.20017517
Prospective Single Center Cohort Study for Early Diagnosis of Cardiac Dysfunction in Swiss Childhood Cancer Survivors: A Study Protocol
Christina Schindera, Claudia Elisabeth Kuehni, Mladen Pavlovic, Eva Haegler-Laube, Nicolas Waespe, Jochen Roessler, Thomas Martin Suter, Nicolas Xavier von der Weid

medRxiv 2020.01.10.20017152; doi: https://doi.org/10.1101/2020.01.10.20017152
Optimizing Clinical Outcome and Toxicity in Lung Cancer Using a Genomic Marker of Radiosensitivity
Jacob G Scott, Geoffrey Sedor, Michael W Kattan, Jeffrey Peacock, G. Daniel Grass, Eric A Mellon, Ram Thapa, Michael Schell, Anthony Waller, Sean Poppen, George Andl, Steven Eschrich, Thomas Dilling, William Dalton, Louis Harrison, Tim Fox, Javier Torres-Roca

medRxiv 2020.01.09.20017046; doi: https://doi.org/10.1101/2020.01.09.20017046
Expanding cancer predisposition genes with ultra-rare cancer-exclusive human variations
Roni Rasnic, Nathan Linial, Michal Linial

medRxiv 2020.01.09.19015867; doi: https://doi.org/10.1101/2020.01.09.19015867
Molecular Profiling of Breast Cancer Susceptibility of Obese or Insulin-Resistant and Pre-Diabetic Patients Using ITLN1 and CD295 SNPs
Nadia M Hamdy, Reham A El-Shemy

medRxiv 2020.01.08.20016980; doi: https://doi.org/10.1101/2020.01.08.20016980
Efficacy and Safety of PD-1/PD-L1 plus CTLA-4 antibodies +/- Other Therapies in Lung Cancer: A Systematic Review and Meta-Analysis
xiong bin

medRxiv 2020.01.08.20016915; doi: https://doi.org/10.1101/2020.01.08.20016915
Circulating tumor cell characterization of lung cancer brain metastasis in the cerebrospinal fluid through single-cell transcriptome analysis
Haoyu Ruan, Yihang Zhou, Jie Shen, Yue Zhai, Ying Xu, Linyu Pi, RuoFan Huang, Kun Chen, Xiangyu Li, Weizhe Ma, Zhiyuan Wu, Xuan Deng, Xu Wang, Chao Zhang, Ming Guan

medRxiv 2020.01.06.20016683; doi: https://doi.org/10.1101/2020.01.06.20016683
Surgical candidacy and treatment uptake among women with cervical cancer at public referral hospitals in Kampala, Uganda
Megan Swanson, Nakalembe MIRIAM, Lee-may Chen, Stefanie Ueda, Jane Namugga, Carol Nakisige, Megan J Huchko

medRxiv 2019.12.31.19016279; doi: https://doi.org/10.1101/2019.12.31.19016279
Everolimus improves the efficacy of dasatinib in the treatment of PDGFRA-driven glioma
Zachary Miklja, Vivek Nand Yadav, Rodrigo Cartaxo, Ruby Siada, Brendan Mullan, Stefanie Stallard, Alyssa Paul, Amy K. Bruzek, Kyle Wierzbicki, Tao Yang, Taylor Garcia, Ian Wolfe, Hemant Parmar, Marcia Leonard, Patricia L. Robertson, Hugh Garton, Sriram Venneti, Chandan Kumar-Sinha, Arul Chinnaiyan, Rajen Mody, Pai P. Manjunath, Timothy N. Phoenix, Bernard L. Marini, Carl Koschmann

medRxiv 2019.12.28.19015974; doi: https://doi.org/10.1101/2019.12.28.19015974
Radiomics Features of ¹⁸F-fluorodeoxyglucose Positron-Emission Tomography as a Novel Prognostic Signature in Colorectal Cancer
Jeonghyun Kang, Jae-Hoon Lee, Hye Sun Lee, Eun-Suk Cho, Eun Jung Park, Seung Hyuk Baik, Kang Young Lee, Chihyun Park, Yunku Yeu, Jean Rene Clemenceau, Sunho Park, Hongming Xu, Changjin Hong, Tae Hyun Hwang

medRxiv 2019.12.27.19015982; doi: https://doi.org/10.1101/2019.12.27.19015982

Oncology

Pages